En esta información se explica cómo cuidar de su derivación cutánea continente después de la cirugía. También se explica cómo cateterizar su derivación cutánea continente y seguir un horario de catete ...

Esta información le ayudará a prepararse para su procedimiento de colocación de marcadores de referencia en la próstata, ya que le explica qué esperar antes, durante y después de su procedimiento. Se ...

¿Está tratando de dejar de fumar? Encuentre respuestas a las preguntas frecuentes sobre cómo emprender esta difícil tarea.

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.

Learn about MSK’s Healthy Living, a lifestyle program for people with breast cancer, where diet, nutrition, exercise and integrative medicine come together to improve quality of life.

MSK cellular therapist Dr. Heather Landau led a phase 1 clinical trial showing CAR T cell therapy is effective against relapsed or resistant AL amyloidosis. “I’ve seen very sick patients have an ...

As long-term cancer survival outcomes improve, the brain has increasingly become a site of refractory and recurrent disease. At Memorial Sloan Kettering Cancer Center (MSK), neurosurgeon Nelson Moss, ...

Thetis cells, a class of immune cells first described by MSK researchers in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food, a new study finds.

The first drug for a rare and difficult-to-treat type of ovarian cancer has been granted accelerated approval by the Food and Drug Administration (FDA). The treatment, called avutometinib plus ...

Learn about a clinical trial that used immunotherapy alone to treat people with several different types of cancer, meaning they did not need to undergo surgery, radiation or chemotherapy.

For the first time, a targeted drug is showing promise at treating non-small cell lung cancer caused by a mutation called KRAS-G12D.

Laboratory research shows how it may be possible to develop an immunotherapy-based approach for treating aggressive forms of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).